Skip to content

Evaluation of Dental Implants Placed in Preserved and Non-preserved Post-extraction Ridges

Evaluation of Dental Implants Placed in Preserved Post-extraction Ridges With Leucocyte- and Platelet-rich Fibrin: 1, 3 and 5-year Post-loading Outcome of a Randomized Controlled Trial

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03715439
Enrollment
0
Registered
2018-10-23
Start date
2018-11-13
Completion date
2024-07-01
Last updated
2022-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Bone Loss, Alveolar Rege Preservation, Dental Implant Failed, Platelet-rich Fibrin

Brief summary

A prospective study to evaluate and compare implants placed in preserved versus non-preserved extraction sockets using L-PRF (Leucocyte- and platelet-rich fibrin) after 1, 3 and 5 years.

Interventions

DEVICEDental implant

A single dental implant was inserted 3 months after tooth extraction

Sponsors

Rio de Janeiro State University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Health patients, American Society of Anesthesiologists (ASA) I or II * Patients who need to submit tooth extraction (pre-molar, canine and incisor teeth which present ideal conditions to receive dental implants after 3 months.

Exclusion criteria

* Systemic diseases related with healing disorders * Poor oral hygiene * Pregnant or lactating patient * Use of flap elevation for dental extraction

Design outcomes

Primary

MeasureTime frameDescription
survival rates of the implants1 yearThe term surviving refers to those implants that are still in the jaw of the patient but either have not met success criteria or have not been tested for success.
success rates of the implants1 yearSuccess is graded in three qualities, depending on the extent and results of performed examinations. Grade 1. 1. Absence of mobility is checked by individual stability testing of the unattached implant. 2. Radiographic evaluation of each implant reveals not more than 1.0 mm of marginal bone loss during the first year of loading, followed by not more than 0.2 mm resorption per year. 3. Severe soft tissue infections, persistent pain, paresthesia, discomfort, etc. Grade 2. 1. Radiographic evaluation 2. Severe soft tissue infections, persistent pain, paresthesia, discomfort, etc, are absent. Grade 3. 1. Radiographic evaluation. Peri-implant pathosis, such as a peri-implant radiolucency is absent. 2. Severe soft tissue infections, persistent pain, paresthesia, discomfort, etc, are absent.

Secondary

MeasureTime frameDescription
Marginal Bone Loss1 yearPeriapical digital radiographs will be used to make the measurements and evaluations.
Pink Esthetic Score1 yearThe PES is based on seven variables: mesial papilla, distal papilla, soft-tissue level, soft tissue contour, alveolar process deficiency, soft-tissue color and texture. Each variable was assessed with a 2-1-0 score, with 2 being the best and 0 being the poorest score.
Patient satisfaction - Questions will be scored on 100mm visual analog scales. The patients marked their response on a horizontal line for which the most negative expression corresponded to 0 and the most positive to 100.1 yearQuestions: Are you satisfied with the aesthetic outcome of the gums surrounding this implant? Are you satisfied with the function of your implant-supported tooth? Would you undergo the same procedure again?
Patient satisfaction with single-tooth implant treatment measured with the Oral health impact profile-14 questionnaire1 yearThe questionnaire was divided into seven domains, containing two questions each, resulting in a total of 14 questions. The domains were functional limitation physical disability, physical pain, psychological disability, psychological discomfort, social disability and handicap. The overall OHIP-14 score is the mean of the 14 questions. The questions pertained to seven domains and were averaged on a scale of 0-4, with 0 defined as never a problem and 4 defined as very often a problem.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026